vs

Side-by-side financial comparison of CLEARONE INC (CLRO) and DNA X, Inc. (SONM). Click either name above to swap in a different company.

CLEARONE INC runs the higher net margin — 116.9% vs -29.3%, a 146.2% gap on every dollar of revenue. On growth, CLEARONE INC posted the faster year-over-year revenue change (28.6% vs 7.9%). Over the past eight quarters, DNA X, Inc.'s revenue compounded faster (NaN% CAGR vs NaN%).

ClearOne Inc is a global provider of innovative audio and video communication solutions, including professional conferencing systems, collaboration tools and AV distribution products. It serves enterprise, education, healthcare and live event production segments, delivering solutions for smooth remote and in-person collaboration.

CLRO vs SONM — Head-to-Head

Bigger by revenue
SONM
SONM
-3.8× larger
SONM
$16.2M
$-4.2M
CLRO
Growing faster (revenue YoY)
CLRO
CLRO
+20.7% gap
CLRO
28.6%
7.9%
SONM
Higher net margin
CLRO
CLRO
146.2% more per $
CLRO
116.9%
-29.3%
SONM
Faster 2-yr revenue CAGR
SONM
SONM
Annualised
SONM
9.9%
NaN%
CLRO

Income Statement — Q4 2025 vs Q3 2025

Metric
CLRO
CLRO
SONM
SONM
Revenue
$-4.2M
$16.2M
Net Profit
$-4.9M
$-4.8M
Gross Margin
11.2%
Operating Margin
-24.5%
Net Margin
116.9%
-29.3%
Revenue YoY
28.6%
7.9%
Net Profit YoY
-124.3%
-89.2%
EPS (diluted)
$-4.10
$-4.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLRO
CLRO
SONM
SONM
Q4 25
$-4.2M
Q3 25
$0
$16.2M
Q2 25
$1.9M
$11.2M
Q1 25
$2.3M
$16.7M
Q4 24
$-5.9M
$15.3M
Q3 24
$0
$15.0M
Q2 24
$2.3M
$11.5M
Q1 24
$3.6M
$9.1M
Net Profit
CLRO
CLRO
SONM
SONM
Q4 25
$-4.9M
Q3 25
$-13.7M
$-4.8M
Q2 25
$-4.6M
$-7.5M
Q1 25
$-2.8M
$458.0K
Q4 24
$-2.2M
$-21.6M
Q3 24
$-2.1M
$-2.5M
Q2 24
$-2.8M
$-6.6M
Q1 24
$-1.9M
$-2.9M
Gross Margin
CLRO
CLRO
SONM
SONM
Q4 25
Q3 25
11.2%
Q2 25
-12.1%
7.6%
Q1 25
5.2%
50.0%
Q4 24
-1.2%
Q3 24
28.2%
Q2 24
-0.9%
25.8%
Q1 24
31.8%
31.8%
Operating Margin
CLRO
CLRO
SONM
SONM
Q4 25
Q3 25
-24.5%
Q2 25
-237.9%
-60.2%
Q1 25
-123.0%
3.9%
Q4 24
55.3%
Q3 24
-15.8%
Q2 24
-126.9%
-56.2%
Q1 24
-57.4%
-29.5%
Net Margin
CLRO
CLRO
SONM
SONM
Q4 25
116.9%
Q3 25
-29.3%
Q2 25
-238.6%
-66.8%
Q1 25
-122.5%
2.7%
Q4 24
37.2%
-141.6%
Q3 24
-16.7%
Q2 24
-122.4%
-57.5%
Q1 24
-52.4%
-31.9%
EPS (diluted)
CLRO
CLRO
SONM
SONM
Q4 25
$-4.10
Q3 25
$-7.92
$-4.83
Q2 25
$-2.64
$-0.79
Q1 25
$-0.11
$0.08
Q4 24
$-2.48
$-116.99
Q3 24
$-1.29
$-9.32
Q2 24
$-1.76
$-1.41
Q1 24
$-0.08
$-0.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLRO
CLRO
SONM
SONM
Cash + ST InvestmentsLiquidity on hand
$220.0K
$2.1M
Total DebtLower is stronger
$5.1M
Stockholders' EquityBook value
$-714.0K
$-701.0K
Total Assets
$2.3M
$40.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLRO
CLRO
SONM
SONM
Q4 25
$220.0K
Q3 25
$101.0K
$2.1M
Q2 25
$1.1M
$2.0M
Q1 25
$961.0K
$2.1M
Q4 24
$1.4M
$5.3M
Q3 24
$2.8M
$9.1M
Q2 24
$4.3M
$9.6M
Q1 24
$21.4M
$9.3M
Total Debt
CLRO
CLRO
SONM
SONM
Q4 25
Q3 25
$5.1M
Q2 25
$2.9M
Q1 25
$2.8M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLRO
CLRO
SONM
SONM
Q4 25
$-714.0K
Q3 25
$3.5M
$-701.0K
Q2 25
$14.9M
$-1.3M
Q1 25
$19.5M
$-1.1M
Q4 24
$21.3M
$-5.7M
Q3 24
$23.5M
$15.3M
Q2 24
$25.6M
$17.5M
Q1 24
$28.3M
$19.8M
Total Assets
CLRO
CLRO
SONM
SONM
Q4 25
$2.3M
Q3 25
$9.5M
$40.2M
Q2 25
$24.0M
$36.1M
Q1 25
$24.7M
$36.0M
Q4 24
$26.5M
$39.7M
Q3 24
$28.4M
$49.1M
Q2 24
$30.8M
$45.9M
Q1 24
$48.2M
$42.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLRO
CLRO
SONM
SONM
Operating Cash FlowLast quarter
$-7.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLRO
CLRO
SONM
SONM
Q4 25
Q3 25
$-7.0M
Q2 25
$-1.1M
$-4.9M
Q1 25
$-1.4M
$-9.6M
Q4 24
$-1.5M
$-4.5M
Q3 24
$-1.9M
$-417.0K
Q2 24
$-3.2M
$-3.4M
Q1 24
$433.0K
$-168.0K
Free Cash Flow
CLRO
CLRO
SONM
SONM
Q4 25
Q3 25
Q2 25
Q1 25
$-1.5M
Q4 24
$-1.6M
$-4.5M
Q3 24
$-1.9M
$-554.0K
Q2 24
$-3.2M
$-3.4M
Q1 24
$364.0K
$-198.0K
FCF Margin
CLRO
CLRO
SONM
SONM
Q4 25
Q3 25
Q2 25
Q1 25
-62.9%
Q4 24
26.7%
-29.6%
Q3 24
-3.7%
Q2 24
-139.8%
-29.8%
Q1 24
10.0%
-2.2%
Capex Intensity
CLRO
CLRO
SONM
SONM
Q4 25
Q3 25
Q2 25
0.0%
Q1 25
0.7%
Q4 24
-0.7%
0.1%
Q3 24
0.9%
Q2 24
2.9%
0.3%
Q1 24
1.9%
0.3%
Cash Conversion
CLRO
CLRO
SONM
SONM
Q4 25
Q3 25
Q2 25
Q1 25
-20.97×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons